Casey IRACs are produced by an AI that analyzes the opinion’s content to construct its analysis. While we strive for accuracy, the output may not be flawless. For a complete and precise understanding, please refer to the linked opinions above.

Keywords

statutenonprofit

plaintiffstatuteappellee

Related Cases

Virginia State Bd. of Pharmacy v. Virginia Citizens Consumer Council, Inc., 425 U.S. 748, 96 S.Ct. 1817, 48 L.Ed.2d 346, 1976-1 Trade Cases P 60,930, 1 Media L. Rep. 1930

Facts

The case arose when consumers of prescription drugs, including a Virginia resident and two nonprofit organizations, sued the Virginia State Board of Pharmacy. They argued that the statute prohibiting pharmacists from advertising prescription drug prices violated their First and Fourteenth Amendment rights. The District Court found that the ban on advertising drug prices was unconstitutional, as it suppressed truthful information about lawful activities and did not adequately justify the state's interest in maintaining professional standards among pharmacists.

The present, and second, attack on the statute is one made not by one directly subject to its prohibition, that is, a pharmacist, but by prescription drug consumers who claim that they would greatly benefit if the prohibition were lifted and advertising freely allowed.

Issue

Did the Virginia statute prohibiting licensed pharmacists from advertising the prices of prescription drugs violate the First and Fourteenth Amendments?

The question first arises whether, even assuming that First Amendment protection attaches to the flow of drug price information, it is a protection enjoyed by the appellees as recipients of the information, and not solely, if at all, by the advertisers themselves who seek to disseminate that information.

Rule

The court ruled that commercial speech is protected under the First and Fourteenth Amendments, and that the state cannot suppress truthful information about lawful activities without sufficient justification.

“Commercial speech” is not wholly outside the protection of the First and Fourteenth Amendments, and the Virginia statute is therefore invalid.

Analysis

The court applied the rule by determining that the consumers, as recipients of the information, had a right to receive price information that pharmacists wished to communicate. It emphasized that the ban on advertising was overly broad and unjustified, as it did not address any false or misleading advertisements and instead kept the public uninformed about competitive pricing.

The District Court seized on the identity of the plaintiff-appellees as consumers as a feature distinguishing the present case from Patterson Drug Co. v. Kingery, supra. Because the unsuccessful plaintiffs in that earlier case were pharmacists, the court said, 'theirs was a prima facie commercial approach.'

Conclusion

The Supreme Court affirmed the District Court's ruling, declaring the Virginia statute void and enjoining its enforcement.

Held: 1. Any First Amendment protection enjoyed by advertisers seeking to disseminate prescription drug price information is also enjoyed, and thus may be asserted, by appellees as recipients of such information.

Who won?

Consumers of prescription drugs prevailed in the case because the court recognized their First Amendment rights to receive information about drug prices, which the statute unjustly suppressed.

The Board failed to justify the statute adequately, and it had to fall.

You must be

Log In to Casey

Sign Up to Casey

Reset Your Password

Keywords

Related Cases

In re Guess, 327 N.C. 46, 393 S.E.2d 833

Bonney v. Stephens Memorial Hosp., 17 A.3d 123, 2011 ME 46

Santa Rosa Health Care Corp. v. Garcia, 964 S.W.2d 940, 41 Tex. Sup. Ct. J. 535

Kelly v. VinZant, 287 Kan. 509, 197 P.3d 803

John J. Kane Regional Centers–Glen Hazel v. Grammer, 559 U.S. 939, 130 S.Ct. 1524 (Mem), 176 L.Ed.2d 113, 78 USLW 3374, 78 USLW 3475, 78 USLW 3480